EVE Health Group Limited (EVE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.242x

Based on the latest financial reports, EVE Health Group Limited (EVE) has a cash flow conversion efficiency ratio of -0.242x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-907.94K ≈ $-642.42K USD) by net assets (AU$3.76 Million ≈ $2.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of EVE Health Group Limited to measure how much of total assets are equity-financed.

EVE Health Group Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how EVE Health Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EVE cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

EVE Health Group Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EVE Health Group Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Conifex Timber Inc
TO:CFF
0.005x
FW Thorpe PLC
LSE:TFW
0.081x
Centogene N.V.
NASDAQ:CNTGF
N/A
Destiny Media Technologies Inc
V:DSY
-0.110x
NextEnergy Solar Fund Ltd
LSE:NESF
0.048x
Murchison Minerals Ltd
V:MUR
-0.773x
Au Gold Corp
V:AUGC
-0.023x
Telemasters Holdings Ltd
JSE:TLM
0.033x

Annual Cash Flow Conversion Efficiency for EVE Health Group Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of EVE Health Group Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see EVE Health Group Limited stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$3.55 Million
≈ $2.51 Million
AU$-1.62 Million
≈ $-1.14 Million
-0.455x +49.72%
2024-06-30 AU$1.22 Million
≈ $866.05K
AU$-1.11 Million
≈ $-783.25K
-0.904x -71.38%
2023-06-30 AU$3.12 Million
≈ $2.21 Million
AU$-1.65 Million
≈ $-1.17 Million
-0.528x +3.00%
2022-06-30 AU$6.93 Million
≈ $4.91 Million
AU$-3.77 Million
≈ $-2.67 Million
-0.544x -146.98%
2021-06-30 AU$10.19 Million
≈ $7.21 Million
AU$-2.24 Million
≈ $-1.59 Million
-0.220x +9.31%
2020-06-30 AU$12.99 Million
≈ $9.19 Million
AU$-3.16 Million
≈ $-2.23 Million
-0.243x -32.63%
2019-06-30 AU$5.85 Million
≈ $4.14 Million
AU$-1.07 Million
≈ $-757.90K
-0.183x -67.12%
2018-06-30 AU$7.38 Million
≈ $5.22 Million
AU$-808.76K
≈ $-572.25K
-0.110x +45.55%
2017-06-30 AU$2.78 Million
≈ $1.97 Million
AU$-558.99K
≈ $-395.52K
-0.201x +45.42%
2016-06-30 AU$1.75 Million
≈ $1.24 Million
AU$-645.76K
≈ $-456.92K
-0.369x -305.44%
2015-06-30 AU$2.64 Million
≈ $1.87 Million
AU$-240.46K
≈ $-170.14K
-0.091x -368.93%
2014-06-30 AU$8.11 Million
≈ $5.74 Million
AU$-157.19K
≈ $-111.23K
-0.019x +79.66%
2013-06-30 AU$8.18 Million
≈ $5.79 Million
AU$-779.82K
≈ $-551.77K
-0.095x -39.15%
2012-06-30 AU$23.04 Million
≈ $16.30 Million
AU$-1.58 Million
≈ $-1.12 Million
-0.069x +64.89%
2011-06-30 AU$25.64 Million
≈ $18.14 Million
AU$-5.00 Million
≈ $-3.54 Million
-0.195x -117.47%
2010-06-30 AU$25.15 Million
≈ $17.79 Million
AU$-2.26 Million
≈ $-1.60 Million
-0.090x +29.17%
2009-06-30 AU$22.93 Million
≈ $16.23 Million
AU$-2.91 Million
≈ $-2.06 Million
-0.127x -29.01%
2008-06-30 AU$25.64 Million
≈ $18.14 Million
AU$-2.52 Million
≈ $-1.78 Million
-0.098x -34.67%
2007-06-30 AU$18.78 Million
≈ $13.29 Million
AU$-1.37 Million
≈ $-969.08K
-0.073x -104.92%
2006-06-30 AU$5.98 Million
≈ $4.23 Million
AU$-212.78K
≈ $-150.56K
-0.036x +46.18%
2005-06-30 AU$2.22 Million
≈ $1.57 Million
AU$-146.87K
≈ $-103.92K
-0.066x +70.17%
2004-06-30 AU$251.35K
≈ $177.84K
AU$-55.71K
≈ $-39.42K
-0.222x --

About EVE Health Group Limited

AU:EVE Australia Packaged Foods
Market Cap
$3.46 Million
AU$4.89 Million AUD
Market Cap Rank
#29197 Global
#1624 in Australia
Share Price
AU$0.01
Change (1 day)
-12.50%
52-Week Range
AU$0.01 - AU$0.04
All Time High
AU$0.04
About

EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more